Literature DB >> 22495673

Identification of critical residues involved in ligand binding and G protein signaling in human somatostatin receptor subtype 2.

Jesse J Parry1, Ronald Chen, Rebecca Andrews, Kimberly A Lears, Buck E Rogers.   

Abstract

G protein signaling through human somatostatin receptor subtype 2 (SSTR2) is well known, but the amino acids involved in stimulation of intracellular responses upon ligand binding have not been characterized. We constructed a series of point mutants in SSTR2 at amino acid positions 89, 139, and 140 in attempts to disrupt G protein signaling upon ligand binding. The aspartic acid changes at position 89 to either Ala, Leu, or Arg generated mutant receptors with varying expression profiles and a complete inability to bind somatostatin-14 (SST). Mutations to Asp 139 and Arg 140 also led to varying expression profiles with some mutants maintaining their affinity for SST. Mutation of Arg 140 to Ala resulted in a mutated receptor that had a B(max) and dissociation constant (K(d)) similar to wild-type receptor but was still coupled to the G protein as determined in both a cAMP assay and a calcium-release assay. In contrast, mutation of Asp 139 to Asn resulted in a mutated receptor with B(max) and K(d) values that were similar to wild type but was uncoupled from G protein-mediated cAMP signaling, but not calcium release. Thus, we identified mutations in SSTR2 that result in either receptor expression levels that are similar to wild type but is completely ablated for ligand binding or a receptor that maintains affinity for SST and is uncoupled from G protein-mediated cAMP signaling.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22495673      PMCID: PMC3359596          DOI: 10.1210/en.2011-1662

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  53 in total

1.  Vapreotide in variceal bleeding.

Authors:  David Patch; Andrew Burroughs
Journal:  J Hepatol       Date:  2002-07       Impact factor: 25.083

2.  The tyrosine phosphatase SHP-1 associates with the sst2 somatostatin receptor and is an essential component of sst2-mediated inhibitory growth signaling.

Authors:  F Lopez; J P Estève; L Buscail; N Delesque; N Saint-Laurent; M Théveniau; C Nahmias; N Vaysse; C Susini
Journal:  J Biol Chem       Date:  1997-09-26       Impact factor: 5.157

Review 3.  New aspects in the diagnosis and treatment of Cushing disease.

Authors:  M Labeur; M Theodoropoulou; C Sievers; M Paez-Pereda; V Castillo; E Arzt; G K Stalla
Journal:  Front Horm Res       Date:  2006       Impact factor: 2.606

4.  Noninvasive monitoring of somatostatin receptor type 2 chimeric gene transfer.

Authors:  Vikas Kundra; Finn Mannting; Alun G Jones; Amin I Kassis
Journal:  J Nucl Med       Date:  2002-03       Impact factor: 10.057

5.  Transducin-dependent protonation of glutamic acid 134 in rhodopsin.

Authors:  K Fahmy; T P Sakmar; F Siebert
Journal:  Biochemistry       Date:  2000-08-29       Impact factor: 3.162

Review 6.  Targeted therapy of cancer with radiolabeled antibodies.

Authors:  David M Goldenberg
Journal:  J Nucl Med       Date:  2002-05       Impact factor: 10.057

7.  The two isoforms of the mouse somatostatin receptor (mSSTR2A and mSSTR2B) differ in coupling efficiency to adenylate cyclase and in agonist-induced receptor desensitization.

Authors:  M Vanetti; G Vogt; V Höllt
Journal:  FEBS Lett       Date:  1993-10-04       Impact factor: 4.124

8.  Agonist-dependent dissociation of human somatostatin receptor 2 dimers: a role in receptor trafficking.

Authors:  Michael Grant; Brian Collier; Ujendra Kumar
Journal:  J Biol Chem       Date:  2004-07-01       Impact factor: 5.157

Review 9.  Sequence alignment of the G-protein coupled receptor superfamily.

Authors:  W C Probst; L A Snyder; D I Schuster; J Brosius; S C Sealfon
Journal:  DNA Cell Biol       Date:  1992 Jan-Feb       Impact factor: 3.311

10.  Conversion of antagonist-binding site to metal-ion site in the tachykinin NK-1 receptor.

Authors:  C E Elling; S M Nielsen; T W Schwartz
Journal:  Nature       Date:  1995-03-02       Impact factor: 49.962

View more
  4 in total

1.  Radiolabeling strategies for radionuclide imaging of stem cells.

Authors:  Esther Wolfs; Catherine M Verfaillie; Koen Van Laere; Christophe M Deroose
Journal:  Stem Cell Rev Rep       Date:  2015-04       Impact factor: 5.739

Review 2.  Nanoparticle ligand presentation for targeting solid tumors.

Authors:  Jason T Duskey; Kevin G Rice
Journal:  AAPS PharmSciTech       Date:  2014-06-14       Impact factor: 3.246

3.  Understanding the influence of lipid bilayers and ligand molecules in determining the conformational dynamics of somatostatin receptor 2.

Authors:  Santhosh Kumar Nagarajan; Sathya Babu; Seema A Kulkarni; Aanand Vadivelu; Panneer Devaraju; Honglae Sohn; Thirumurthy Madhavan
Journal:  Sci Rep       Date:  2021-04-07       Impact factor: 4.379

4.  Assessment and challenges of ligand docking into comparative models of G-protein coupled receptors.

Authors:  Elizabeth Dong Nguyen; Christoffer Norn; Thomas M Frimurer; Jens Meiler
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.